Analytical Treatment Interruption (ATI) to Assess the Immune System's Ability to Control HIV in Participants Who Became HIV-infected During the HVTN 704/HPTN 085 AMP Study

NCT04801758 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
18
Enrollment
NETWORK
Sponsor class

Conditions

Interventions

Sponsor

HIV Vaccine Trials Network

Collaborators